COVID-19 Updates – Co-infections, pediatrics, and ibuprofen

Apple Podcasts or Listen Here

We are going to try to bring you daily updates on COVID-19. There is a firehose of information and most of us are too busy to read and digest it all. 

Note: If you are listening to these more than a few days in the future, please beware that information may have changed and check subsequent episodes.

Shah, N. Higher co-infection rates in COVID19. https://medium.com/@nigam/higher-co-infection-rates-in-covid19-b24965088333

Dong Y, Mo X, Hu Y, et al. Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China. Pediatrics. 2020; doi: 10.1542/peds.2020-0702 


Fang et al. Lancet March 11 wrote that ace-inhibitors should be avoided due to concern for worsening COVID-19 severity. This was immediately debunked by the European Society of Cardiology as without any evidence.

An article in the BMJ, mistaken in the news for a study (which it is not), in addition to comments by the Health Minister in France, created a viral panic to avoid ibuprofen for fever of severity. Initially reports stated the WHO recommended individuals avoid ibuprofen, however 3/18/20, the WHO reversed this statement.